The seventh national report on the TREND system


The seventh national report on the TREND system

Tendances n° 52, OFDT, 4 p.
December 2006

This edition of Tendances presents the main results of the seventh year of operation of the TREND system (recent trends and new drugs).
It is important to remember that the TREND system focuses on population groups with a much higher propensity to consume psychotropic substances than the rest of the population of an equivalent age. Consequently, the findings may not be extended to the rest of the population.
Among the highlights noted in 2005, four main points stand out in particular: an increased prevalence of injection practices among the most precarious sectors of the population for HDB and stimulants, changes noted in the consumption of opioids, (including a possible resumption of heroin consumption and an increase in the misuse of HDB among the same marginal groups), a diversification in the methods of use for stimulants, (particularly cocaine and ecstasy) and, finally, in the second part of the report, new phenomena concerning the hallucinogen family including the appearance of a new form of LSD and the use of GHB in particular.

Authors :
Michel Gandhilon, Agnès Cadet-Taïrou, Abdalla Toufik

Download the PDF file (125 Ko)











Drugs in Europe

2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.